Last night I attended a wonderful
@BreastCancerNow event with my sister. One of the important messages it reinforced is to check your breasts regularly and know what is normal for you. Early detection really can save lives.
When breast cancer is found early, survival rates are extremely high. But the reality becomes very different when the disease spreads beyond the breast like mine.
For those of us living with metastatic (Stage 4) breast cancer, the five year survival rate is only around 29%.
When you are living with an incurable diagnosis and have so few treatment lines available, time is everything. That is why it is utterly incomprehensible that
@NICEComms is still denying us
#Enhertu, a targeted, life extending drug already provided in over 70 countries worldwide, including Scotland. They claim we aren’t "cost-effective."
For those of us whose lives depend on access to new treatments, those words are incredibly hard to hear.
Breast cancer remains the leading cause of death for women under 60 in the UK. 31 women die from it every single day. That’s 11,500 mothers, sisters, daughters, friends and colleagues lost every year. How can this gatekeeping be justified, especially when new funding thresholds were introduced in April to allow the NHS to spend more on severe, life threatening diseases?
Our lives should not be reduced to a spreadsheet column.
Please, if you do one thing today, sign and share the Enhertu petition. Help us force NICE and the manufacturers
@DaiichiSankyoUK and
@ASTRAZENECAUK
back to the table. We deserve a deal, we deserve more time and we need it now ⬇️
action.breastcancernow.org/s…